Stephen P. J. Fancy

Stephen P. J. Fancy

Auto-generated profile, based on publicly available information

Stephen P. J. Fancy

Department of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in Science
Verified
Journal Article
Closed access
PDF file
HTHui-Hsin Tsai
Hui-Hsin Tsai
JNJianqin Niu
Jianqin Niu
RMRoeben Munji
Roeben Munji
DDDimitrios Davalos
Dimitrios Davalos
JCJunlei Chang
Junlei Chang
SFStephen P. J. Fancy
Stephen P. J. Fancy
Neuronal migrations follow vascular pathways: In the developing brain, various types of cells migrate from their birthplaces to their workplaces. Oligodendrocyte precursors, which develop to form the insulating sheaths that make signal transmission along an axon faster, travel farther than many. Tsai et al. now show just how the oligodendrocyte precursor cells find their way (see the Perspective by Dejana and Beltsholtz). The progenitor cells follow along the endothelial cells of the vasculature. Disrupting endothelial cells interfered with oligodendrocyte migration, leaving some sections of the brain deficient in insulators. Science , this issue p. 379 ; see also p. 341

15 April 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JNJianqin Niu
Jianqin Niu
HTHui-Hsin Tsai
Hui-Hsin Tsai
KHKimberly K. Hoi
Kimberly K. Hoi
NHNanxin Huang
Nanxin Huang
GYGuangdan Yu
Guangdan Yu
SFStephen P. J. Fancy
Stephen P. J. Fancy

1 February 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CDCayce E. Dorrier
Cayce E. Dorrier
DADvir Aran
Dvir Aran
EHEzekiel A. Haenelt
Ezekiel A. Haenelt
RSRyan N. Sheehy
Ryan N. Sheehy
KHKimberly K. Hoi
Kimberly K. Hoi
RDRichard Daneman
Richard Daneman

27 October 2022 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
KLKun Leng
Kun Leng
IRIndigo V. L. Rose
Indigo V. L. Rose
HKHyosung Kim
Hyosung Kim
WXWenlong Xia
Wenlong Xia
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
MKMartin Kampmann
Martin Kampmann

9 March 2014 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SFStephen P J Fancy
Stephen P J Fancy
EHEmily P Harrington
Emily P Harrington
SBSergio Baranzini
Sergio Baranzini
JSJohn C Silbereis
John C Silbereis
LSLawrence R Shiow
Lawrence R Shiow
DRDavid H Rowitch
David H Rowitch
Much of what we know about the signal transduction machinery of the canonical Wnt pathway comes from studying the colon, where low- versus high-activity Wnt signaling states are known to distinguish normal colon epithelium turnover from colorectal cancer. Here, Fancy et al. demonstrate that a pathological Wnt activity state akin to that in colon cancer exists in oligodendrocyte precursor cells in human neonatal white matter injury, which leads to detrimental maturation arrest of these cells. These oligodendrocyte precursors in human newborn brain injury express multiple genes in common with colon cancer, demonstrating a pathological Wnt tone in non-genetic human disease. In colon cancer, mutation of the Wnt repressor APC (encoding adenomatous polyposis coli) leads to a state of aberrant and unrestricted high-activity signaling. However, the relevance of high Wnt tone in non-genetic human disease is unknown. Here we demonstrate that distinct functional states of Wnt activity determine oligodendrocyte precursor cell (OPC) differentiation and myelination. Mouse OPCs with genetic Wnt dysregulation (high tone) express multiple genes in common with colon cancer, including Lef1, Sp5, Ets2, Rnf43 and Dusp4. Surprisingly, we found that OPCs in lesions of hypoxic human neonatal white matter injury upregulated markers of high Wnt activity and lacked expression of APC. We also found that lack of Wnt repressor tone promoted permanent white matter injury after mild hypoxic insult. These findings suggest a state of pathological high-activity Wnt signaling in human disease tissues that lack predisposing genetic mutation.

13 December 2017 in Brain
Verified
Journal Article
Open access
PDF file
BCBruce A C Cree
Bruce A C Cree
JNJianqin Niu
Jianqin Niu
KHKimberly K Hoi
Kimberly K Hoi
CZChao Zhao
Chao Zhao
SCScott D Caganap
Scott D Caganap
SFStephen P J Fancy
Stephen P J Fancy
Hypoxia can injure brain white matter tracts, comprised of axons and myelinating oligodendrocytes, leading to cerebral palsy in neonates and delayed post-hypoxic leukoencephalopathy (DPHL) in adults. In these conditions, white matter injury can be followed by myelin regeneration, but myelination often fails and is a significant contributor to fixed demyelinated lesions, with ensuing permanent neurological injury. Non-myelinating oligodendrocyte precursor cells are often found in lesions in plentiful numbers, but fail to mature, suggesting oligodendrocyte precursor cell differentiation arrest as a critical contributor to failed myelination in hypoxia. We report a case of an adult patient who developed the rare condition DPHL and made a nearly complete recovery in the setting of treatment with clemastine, a widely available antihistamine that in preclinical models promotes oligodendrocyte precursor cell differentiation. This suggested possible therapeutic benefit in the more clinically prevalent hypoxic injury of newborns, and we demonstrate in murine neonatal hypoxic injury that clemastine dramatically promotes oligodendrocyte precursor cell differentiation, myelination, and improves functional recovery. We show that its effect in hypoxia is oligodendroglial specific via an effect on the M1 muscarinic receptor on oligodendrocyte precursor cells. We propose clemastine as a potential therapy for hypoxic brain injuries associated with white matter injury and oligodendrocyte precursor cell maturation arrest.